143 related articles for article (PubMed ID: 8911510)
1. Association of radionuclide bone scan and serum alkaline phosphatase in patients with metastatic renal cell carcinoma.
Seaman E; Goluboff ET; Ross S; Sawczuk IS
Urology; 1996 Nov; 48(5):692-5. PubMed ID: 8911510
[TBL] [Abstract][Full Text] [Related]
2. Normal alkaline phosphatase levels in patients with bone metastases due to renal cell carcinoma.
Kriteman L; Sanders WH
Urology; 1998 Mar; 51(3):397-9. PubMed ID: 9510341
[TBL] [Abstract][Full Text] [Related]
3. Value of serum alkaline phosphatase and radionuclide bone scans in patients with renal cell carcinoma.
Atlas I; Kwan D; Stone N
Urology; 1991 Sep; 38(3):220-2. PubMed ID: 1887534
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
[TBL] [Abstract][Full Text] [Related]
5. Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans.
Shvarts O; Lam JS; Kim HL; Han KR; Figlin R; Belldegrun A
J Urol; 2004 Sep; 172(3):867-70. PubMed ID: 15310985
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers.
Mani S; Todd MB; Katz K; Poo WJ
J Urol; 1995 Jul; 154(1):35-40. PubMed ID: 7539867
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of bone scan in patients with renal cell carcinoma.
Koga S; Tsuda S; Nishikido M; Ogawa Y; Hayashi K; Hayashi T; Kanetake H
J Urol; 2001 Dec; 166(6):2126-8. PubMed ID: 11696720
[TBL] [Abstract][Full Text] [Related]
8. Serum gamma glutamyl-transferase is a sensitive but unspecific marker of metastatic renal cell carcinoma.
Simic T; Dragicevic D; Savic-Radojevic A; Cimbaljevic S; Tulic C; Mimic-Oka J
Int J Urol; 2007 Apr; 14(4):289-93. PubMed ID: 17470155
[TBL] [Abstract][Full Text] [Related]
9. Treatment of osseous metastases in patients with renal cell carcinoma.
Jung ST; Ghert MA; Harrelson JM; Scully SP
Clin Orthop Relat Res; 2003 Apr; (409):223-31. PubMed ID: 12671506
[TBL] [Abstract][Full Text] [Related]
10. [Bone metastasis secondary to renal carcinoma diagnosed with bone scintigraphy].
Ruiz Hernández G; Ferrer Albiach C; Balaguer Martínez JV; Romero de Avila C; Castillo Pallarés FJ
Actas Urol Esp; 2001 Oct; 25(9):679-82. PubMed ID: 11765556
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.
Ramankulov A; Lein M; Kristiansen G; Meyer HA; Loening SA; Jung K
J Cancer Res Clin Oncol; 2007 Sep; 133(9):643-52. PubMed ID: 17479289
[TBL] [Abstract][Full Text] [Related]
12. Is there a diagnostic role for bone scanning of patients with a high pretest probability for metastatic renal cell carcinoma?
Staudenherz A; Steiner B; Puig S; Kainberger F; Leitha T
Cancer; 1999 Jan; 85(1):153-5. PubMed ID: 9921987
[TBL] [Abstract][Full Text] [Related]
13. Patient survival after surgery for osseous metastases from renal cell carcinoma.
Lin PP; Mirza AN; Lewis VO; Cannon CP; Tu SM; Tannir NM; Yasko AW
J Bone Joint Surg Am; 2007 Aug; 89(8):1794-801. PubMed ID: 17671020
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic elevation of serum alkaline phosphatase in renal cell carcinoma: incidence and implication on prognosis.
Chuang YC; Lin AT; Chen KK; Chang YH; Chen MT; Chang LS
J Urol; 1997 Nov; 158(5):1684-7. PubMed ID: 9334578
[TBL] [Abstract][Full Text] [Related]
15. The role of gamma-glutamyl transpeptidase in the preoperative metastatic evaluation of renal cell carcinoma.
Sandock DS; Seftel AD; Resnick MI
J Urol; 1997 Mar; 157(3):798-9. PubMed ID: 9072569
[TBL] [Abstract][Full Text] [Related]
16. Concomitant radiotherapy and transarterial chemoembolization reduce skeletal-related events related to bone metastases from renal cell carcinoma.
Heianna J; Makino W; Ariga T; Ishikawa K; Kusada T; Maemoto H; Toguchi M; Ito J; Goya M; Miyazato M; Iraha Y; Murayama S
Eur Radiol; 2020 Mar; 30(3):1525-1533. PubMed ID: 31728686
[TBL] [Abstract][Full Text] [Related]
17. Massive endoprosthetic replacement for bone metastases resulting from renal cell carcinoma: factors influencing patient survival.
Hwang N; Nandra R; Grimer RJ; Carter SR; Tillman RM; Abudu A; Jeys LM
Eur J Surg Oncol; 2014 Apr; 40(4):429-34. PubMed ID: 24063967
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of bone-specific alkaline phosphatase for bone metastases detection in prostate cancer].
Rasch-Isla Muñoz A; Cataño Cataño JG
Arch Esp Urol; 2004 Sep; 57(7):693-8. PubMed ID: 15536950
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of bone metastases from renal cell carcinoma].
Hoshi S; Orikasa S; Yoshikawa K; Metoki R; Tochigi T; Ono K; Saitoh S; Satoh M; Ohyama C; Suzuki K
Nihon Hinyokika Gakkai Zasshi; 1991 Apr; 82(4):649-54. PubMed ID: 2051704
[TBL] [Abstract][Full Text] [Related]
20. Value of procollagen type 1 amino-terminal propeptide in patients with renal cell carcinoma.
Klepzig M; Sauer-Eppel H; Jonas D; Oremek GM
Anticancer Res; 2008; 28(4C):2443-6. PubMed ID: 18751432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
